Exogenous luteinizing hormone activity may influence the treatment outcome in in vitro fertilization but not in intracytoplasmic sperm injection cycles-Reference-Cited by-同舟云学术

Exogenous luteinizing hormone activity may influence the treatment outcome in in vitro fertilization but not in intracytoplasmic sperm injection cycles

Published:2004-05 Issue:5 Volume:81 Page:1401-1404
ISSN:0015-0282
Container-title:Fertility and Sterility
language:en
Short-container-title:Fertility and Sterility

Author:

Platteau Peter,Smitz Johan,Albano Carola,Sørensen Per,Arce Joan-Carles,Devroey Paul

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Reproductive Medicine

Reference16 articles.

1. Van Wely M, Westergaard LG, Bossuyt PM, Van der Veen F. Human menopausal gonadotropin versus recombinant follicle stimulation hormone for ovarian stimulation in assisted reproductive cycles. Cochrane Database Syst Rev 2003;(1):CD003973

2. A randomized prospective assessor-blind evaluation of luteinizing hormone dosage and in vitro fertilization outcome;Gordon;Fertil Steril,2001

3. Human menopausal gonadotropin versus recombinant follicle-stimulating hormone in normogonadotropic women down-regulated with a gonadotropin-releasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmic sperm injection;Westergaard;Fertil Steril,2001

4. HMG is as good as recombinant human FSH in terms of oocytes and embryo quality;Ng;Hum Reprod,2001

5. Efficacy and safety of highly purified menotropin versus recombinant follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection cycles;Fertil Steril,2002

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The therapeutic effects of rFSH versus uFSH/uHMG on ovarian stimulation in women undergoing assisted reproductive technology: a meta-analysis of randomized controlled trials;Archives of Gynecology and Obstetrics;2023-07-20

2. Highly purified-hMG versus rFSH in ovarian hyperstimulation in women undergoing elective fertility preservation;2023-02-13

3. Rooted in pre-assisted reproductive technology times menotropins are still used today: a narrative review of literature;F&S Reviews;2021-07

4. Supplementation with human menopausal gonadotropin in the gonadotropin-releasing hormone antagonist cycles of women with high AMH: Pregnancy outcomes and serial hormone levels;Taiwanese Journal of Obstetrics and Gynecology;2021-07

5. Randomized controlled trial comparing embryonic quality in rFSH versus hMG in IVF protocol with GnRH Antagonist;JBRA Assisted Reproduction;2020